Skip to main content
MNKD
NASDAQ Life Sciences

FDA Releases MannKind from Major Afrezza Postmarketing Study; Pediatric Decision Due Tomorrow

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$3.668
Mkt Cap
$1.097B
52W Low
$2.23
52W High
$6.51
52W Position info
64% above low
Off High info
44% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

MNKD sits 64% above its 52-week low of $2.23.

Summary

The FDA has released MannKind from the five-year pulmonary malignancy postmarketing study for its drug Afrezza, removing a significant regulatory burden and de-risking the product. This follows the 8-K filed earlier today. Additionally, the company faces a PDUFA date tomorrow, May 29, 2026, for the pediatric efficacy and safety assessment of Afrezza for ages 4-17. A positive decision could expand Afrezza's market. The PDUFA decision tomorrow is a key event to watch.

At the time of this announcement, MNKD was trading at $3.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $2.23 to $6.51. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

MNKD - Latest Insights

MNKD
Nov 05, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.79
Real-time Price: $4.13 info
Change: +$0.340 (+9%) info
Market Cap: $1.328B info
MNKD
Nov 05, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $3.76
Real-time Price: $4.13 info
Change: +$0.370 (+10%) info
Market Cap: $1.328B info
MNKD
Sep 09, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.28
Real-time Price: $4.13 info
Change: -$0.150 (-4%) info
Market Cap: $1.328B info
MNKD
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.12
Real-time Price: $4.13 info
Change: +$0.0100 (+0.24%) info
Market Cap: $1.328B info
MNKD
Jul 29, 2026, 6:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $4.03
Real-time Price: $4.13 info
Change: +$0.100 (+2%) info
Market Cap: $1.328B info